Henri A. Termeer, former CEO, Chairman and President of Genzyme Corporation. Mr. Termeer was appointed president of Genzyme in 1983 became its chief executive officer in 1985 and chairman in 1988. He retired from Genzyme in June 2011 following the acquisition of Genzyme by Sanofi in a transaction valued at more than $20 billion. Widely acknowledged for his contributions to the biotechnology industry and health care field, Mr. Termeer was active in the areas of humanitarian assistance, policy issues and innovation in providing access to health care. Mr. Termeer was a Board member of Massachusetts Institute of Technology Corporation and served on its Executive Committee, a director of Massachusetts General Hospital, board member of Partners HealthCare, and a member of the Board of Fellows of Harvard Medical School. He sat on the boards of Biotechnology Industry Organization (BIO), Life Sciences Foundation, Boston Ballet, Museum of Science, Project Hope and WGBH. He also served on the boards of Abiomed, Inc., AVEO Pharmaceuticals, Moderna Therapeutics, ProQR Therapeutics, and Verastem, Inc. Mr. Termeer was a member of the board of the Federal Reserve Bank of Boston from 2007-2011 and its chairman from 2010-2011. Mr. Termeer studied economics at the Economische Hogeschool (Erasmus University, The Netherlands) and earned an M.B.A from the Darden Business School at the University of Virginia.